Following a period of unusually icy weather in Central Europe earlier this month, Cold Chain Technologies (CCT) has issued a ...

WHO refuted US claims of failure and politicization, emphasizing its impartiality and historical contributions to global health. US WHO withdrawal triggers pharma regulatory and supply chain risks ...

The biopharmaceutical industry loses approximately $35 billion annually due to temperature-control failures within the supply chain, which often results in products being damaged or destroyed.

Heightened regulatory oversight of pharmaceutical distribution is reshaping South Africa’s logistics sector, placing ...

DUSSELDORF, Germany (Reuters) -DHL said on Monday it will acquire U.S. pharmaceutical logistics firm Cryopdp as part of the German company's efforts to grow its operations in the pharma sector, ...

Strategic expansion positions Singapore as a strategic arm for healthcare logistics in the APAC region. DHL Group invests €10 ...

Cencora is enhancing its third-party logistics (3PL) capabilities in the U.S. and Europe, expanding its global network and strengthening specialty logistics services for pharmaceutical companies ...

The pharmaceutical industry relies on high-quality medical product manufacturing. Every stage of the production process is critical, from the early stages, where a medication’s key components and ...

A PHARMACEUTICAL logistics and distribution hub within the Clark Aviation Capital inside the Clark Freeport Zone will soon rise following the signing of a memorandum of understanding (MOU) between ...

Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies Cencora, a global pharmaceutical solutions company, ...

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving ...

When you can’t find specialized talent in the usual places, it undermines timelines for R&D, clinical trials, and commercialization. But there are other locations that employers can explore when ...